Overcome your challenges in consuming and analyzing overwhelming quantities of data from multiple disparate sources with next generation artificial intelligence (AI)
Informa Pharma Intelligence Apps, powered by Signals Analytics, help you significantly reduce your costs and time-to-market by gaining access to timely and relevant novel insights.
How we help
Identify new opportunities, mitigate investment risk and accelerate the drug development process through Informa Pharma Intelligence Apps.
Signals Analytics’ proprietary AI-engines harmonizes the best-in-class content from our suite of solutions and commonly accessed public forums, creating an agile dataset that provide you with timely, relevant, and complete insights through three unique interfaces.
Designed to answer the most common business questions in a single view, use Informa Pharma Intelligence Apps to:
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Pharma Intelligence Apps, Citeline
Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, and Signals Analytics, the next generation advanced analytics platform that leverages external data to uncover trends and novel insights, today announced a joint offering that helps life sciences companies to identify new opportunities, mitigate investment risks and accelerate the drug development process.
Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.
London – 30 October, 2019 – Informa Pharma Intelligence is pleased to announce that The Citeline Awards (previously known as the CARE Awards) is returning for their second year. The awards will once again be held in Boston, MA at the Hyatt Regency, on April 30, 2020.
LONDON – September 30, 2019 – Informa Pharma Intelligence and Saama Technologies today announced a strategic partnership enabling Informa's Citeline and Saama's Life Science Analytics Cloud (LSAC) customers to apply world-class AI to both Citeline clinical intelligence expertise and real world evidence to design clinical trials which better serve the needs of both the customers and their patients.
To increase flexibility and efficiency in drug development, master protocols have emerged as an innovative clinical trial design, including basket and umbrella trials. Learn more about how these approaches are being used within oncology research through an overview of the clinical landscape, trial outcomes and trends.
Citeline, Pink Sheet
Rising costs, patient recruitment issues, shifting regulations, and more are making bringing new drugs to market more difficult than ever. Explore changes in clinical trial design being adopted in response to these challenges with reporting from Pink Sheet.
KNect365 Life Sciences recently conducted a survey into the clinical trial industry at its most interesting point to date, as organisations are implementing new technologies and trends such as AI, virtual trials and wearables. The final report, based on 214 responses, reveals unique insights into what current benefits and challenges companies are facing in the processes of applying these new approaches to therapeutic development. Citeline introduces the report, exploring what some of the key takeaways mean for the industry.
With opioid abuse and deaths in the US at an all-time high, the journey to battle the opioid epidemic continues – keeping drug companies and the FDA working hard to come up with effective alternatives for pain.
For a snapshot of the new active substances (NAS) successfully launched last year, download the data-packed New Active Substances (NAS) Launched During 2018 infographic from Citeline.
Citeline, Sitetrove, Trialtrove, Pharmaprojects
Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.
The average cost of bringing a new drug to market continues to rise, with varying levels of investments across the highly competitive biopharmaceutical industry. To assess the potential effect of varying investments on trial activity and operations, this article reviews trial benchmarks within the active oncology therapeutic area. Industry-sponsored clinical trials across all oncology indications covered by Informa Pharma Intelligence’s Trialtrove were assessed, comparing metrics by company size based on pharma sales, and the identical benchmarks for breast cancer and rare cancers were also analyzed.
Skipta, the leading social network of specialized online medical communities for verified healthcare professionals, recently hosted a virtual advisory board session, through its proprietary Skipta Gather technology, asking physicians what they saw as the current unmet needs in the treatment of rheumatoid arthritis (RA).